TABLE 3.
Laboratory and Radiological Exams Before and After Treatment
| A. Laboratory Exams of Hepatitis C Virus Treated Group | ||||||||
|---|---|---|---|---|---|---|---|---|
| Laboratory Exams of HCV Treated Group (n° = 29) | ||||||||
| Before Therapy | After Therapy | |||||||
| Median | Range | Median | Range | |||||
| ALT (U/L) | 42 | 19–184 | 20 | 11–32 | ||||
| AST (U/L) | 35 | 24–92 | 24 | 12–44 | ||||
| HCV RNA (IU/mL) | 3,900,228 | 37,118–9,481,391 | 0 | 0 | ||||
| B. Radiological Exams of Hepatitis C Virus Treated Group | ||||||||
|---|---|---|---|---|---|---|---|---|
| Abnormal Radiological Exams of HCV Treated Group (n° = 29) | ||||||||
| Before Therapy | After Therapy | |||||||
| N° | % | Median (kPa) | Range | N° | % | Median (kPa) | Range | |
| Abnormal abdominal ultrasound | 7 | 24 | 3 (of 20) | 15 | ||||
| Abnormal elastography | 6 | 23 | 9 | 7–15 | 1 (of 17) | 6 | 8 | 3–9 |
Table A: Median values before and after antiviral treatment of ALT (alanine transaminase), AST (aspartate transaminase) and HCV RNA viral load; Table B: Numbers of patients with pathologic radiological exams (abdominal US and elastography) before and after treatment in patients at the end of the follow-up when available.